OpenVSafe by OpenVAERS
Search V-safe

65B-15512-27411

3 vaccinations 2 coded responses 13 check-ins 1 free-text entry 0 call cases
Sex
Male
Age at first dose
0-4
ZIP prefix
032 / NH
Registered
2022-07-23
Relationship
Child or adolescent in my care
Guardian
UM4-19675-65817
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-11-30
    Dose 1 — Pfizer-BioNTech
  2. 2021-12-21
    Dose 2 — Pfizer-BioNTech
  3. 2022-07-21
    Dose 3 — Pfizer-BioNTech
  4. 2022-07-23
    Registered in v-safe
  5. 2022-07-23
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2022-07-24
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · None
    Adult check-in
  7. 2022-07-25
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · None
    Adult check-in
  8. 2022-07-26
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · None
    Adult check-in
  9. 2022-07-27
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · None
    Adult check-in
  10. 2022-07-28
    Health check-in — day 7, dose 3, dependent
    Feeling: Good · Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  11. 2022-08-04
    Health check-in — day 14, dose 3, dependent
    Feeling: Good
    Adult check-in
  12. 2022-08-11
    Health check-in — day 21, dose 3, dependent
    Feeling: Good
    Adult check-in
  13. 2022-08-18
    Health check-in — day 28, dose 3, dependent
    Feeling: Good
    Adult check-in
  14. 2022-08-25
    Health check-in — day 35, dose 3, dependent
    Feeling: Good
    Adult check-in
  15. 2022-09-01
    Health check-in — day 42, dose 3, dependent
    Feeling: Good
    Adult check-in
  16. 2022-10-22
    Survey response — 3 months, dose 3, dependent
    MedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school
    Free text: Several colds. All Covid neg.
    MedDRA releases: 2024-11 · check-in free text available
  17. 2023-01-19
    Survey response — 6 months, dose 3, dependent
    MedDRA: Upper respiratory tract infection — Feeling: Good · Be unable to work or attend school
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12021-11-30Pfizer-BioNTech No
22021-12-21Pfizer-BioNTech No
32022-07-21Pfizer-BioNTech No

Free text

Release 12 — 3 months, dose 3, dependent

2022-10-22

Symptoms: Several colds. All Covid neg.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDNasopharyngitis · · ✓
SDSARS-CoV-2 test negative · · ✓
SDUpper respiratory tract infection · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release